Disease areas

We have a long-standing commitment to addressing disease areas where we believe peptide therapies can make a difference for people living with unmet medical needs.

Crowd 1

Obesity

Obesity and overweight is a complex chronic disease that requires long term management. More than 220 complications and co-morbidities, including cardiovascular disease, liver disease, type 2 diabetes, kidney disease, and neuroinflammation are associated with obesity.

  • Learn about obesity
  • AR Mike Sherels With Child 2

    Rare diseases

    We are focused on two very different rare diseases where peptide-based therapies have potential to address significant unmet needs and improve lives: congenital hyperinsulinism (CHI) and short bowel syndrome (SBS)

  • Learn about CHI
  • Learn about SBS
  • Zealand Pharma 1102

    Chronic inflammation

    Chronic inflammation plays a role in many diseases and conditions that are leading causes of death worldwide.

  • Learn about Chronic inflammation
  • ZEALAND AR 2018 Anders0829 B3A5770

    Type 1 Diabetes

    Achieving tight control over blood-glucose levels remains a daily challenge for those living with type 1 diabetes.

  • Learn about T1DM
  • Crowd 1 AR Mike Sherels With Child 2 Zealand Pharma 1102 ZEALAND AR 2018 Anders0829 B3A5770

    Patient stories

    Crosby was born with CHI

    Congenital Hyperinsulinism

    Julie and her husband, knew during pregnancy that Crosby, would be born with congenital hyperinsulinism (CHI): an ultra-rare genetic disorder that causes the insulin cells of the pancreas, called beta cells, to secrete too much insulin. The disorder may cause Crosby to have cognitive and physical disabilities if not treated adequately.

    READ MY STORY
    Crosby CHI NJ USA JW 0767 B3A5926

    Marianne lives with Short Bowel Syndrome

    Short Bowel Syndrome

    Marianne was diagnosed with cancer of the small intestine and became a short bowel patient. Today, she manages to live a life on home parenteral nutrition and works as a pastor.

    READ MY STORY
    1600Px COLOURBOX31313753

    Mike gets back in the game while living with SBS

    Short Bowel Syndrome

    Dependent on parenteral support to survive, Mike must connect to infusion equipment for eight hours a day, six days a week. Reducing the complexity – and time spent – for parenteral support enabled this driven college football coach to get back in the game.

    READ MY STORY
    AR Mike Sherels With Child 2.39.1 Adj

    Will works to reduce his need for parenteral support

    Short Bowel Syndrome

    After a stomach pain and a black out in his home, then 13-year old Will was rushed to a local hospital in New Jersey, where the doctors discovered a volvulus and most of his small intestine was removed.

    READ MY STORY
    Billyciolino SBS NJ USA JW 0904 B3A6983 800Px

    I hear from our employees every day how important it is to them that the work we do contributes to making a difference in peoples lives.

    Christina Sonnenborg Bredal

    Chief People Officer

    Christina ALR0693 V2

    Latest news

    View all news
    • COMPANY ANNOUNCEMENT

      Zealand Pharma announces positive topline results from the Phase 1b 16-week multiple ascending dose clinical trial with long-acting amylin analog petrelintide

      READ MORE
    • COMPANY ANNOUNCEMENT

      Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants

      READ MORE
    • COMPANY ANNOUNCEMENT

      Zealand Pharma announces that Boehringer Ingelheim’s survodutide demonstrates breakthrough improvement in liver fibrosis with no worsening of MASH in 64.5% of patients with F2 and F3 fibrosis

      READ MORE
    • COMPANY ANNOUNCEMENT

      Zealand Pharma announces that Boehringer Ingelheim will present positive results from Phase 2 trial with survodutide in MASH at EASL

      READ MORE